These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6726003

  • 1. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge.
    Belshe RB, Van Voris LP.
    J Infect Dis; 1984 May; 149(5):735-40. PubMed ID: 6726003
    [Abstract] [Full Text] [Related]

  • 2. Live attenuated influenza A virus vaccines in children: results of a field trial.
    Belshe RB, Van Voris LP, Bartram J, Crookshanks FK.
    J Infect Dis; 1984 Dec; 150(6):834-40. PubMed ID: 6501927
    [Abstract] [Full Text] [Related]

  • 3. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB, Swierkosz EM, Anderson EL, Newman FK, Nugent SL, Maassab HF.
    J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
    [Abstract] [Full Text] [Related]

  • 4. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
    Miyazaki C, Nakayama M, Tanaka Y, Kusuhara K, Okada K, Tokugawa K, Ueda K, Shibata R, Nishima S, Yamane N.
    Vaccine; 1993 Apr; 11(8):853-8. PubMed ID: 8356846
    [Abstract] [Full Text] [Related]

  • 5. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
    Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH.
    J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
    [Abstract] [Full Text] [Related]

  • 6. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
    Clements ML, Betts RF, Murphy BR.
    Lancet; 1984 Mar 31; 1(8379):705-8. PubMed ID: 6143042
    [Abstract] [Full Text] [Related]

  • 7. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
    Clements ML, O'Donnell S, Levine MM, Chanock RM, Murphy BR.
    Infect Immun; 1983 Jun 31; 40(3):1044-51. PubMed ID: 6852910
    [Abstract] [Full Text] [Related]

  • 8. Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus.
    Lazar A, Okabe N, Wright PF.
    Infect Immun; 1980 Mar 31; 27(3):862-6. PubMed ID: 6155338
    [Abstract] [Full Text] [Related]

  • 9. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses.
    Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB.
    J Infect Dis; 1991 Feb 31; 163(2):300-4. PubMed ID: 1988512
    [Abstract] [Full Text] [Related]

  • 10. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.
    Steinhoff MC, Halsey NA, Wilson MH, Burns BA, Samorodin RK, Fries LF, Murphy BR, Clements ML.
    J Infect Dis; 1990 Aug 31; 162(2):394-401. PubMed ID: 2197335
    [Abstract] [Full Text] [Related]

  • 11. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
    Feldman S, Wright PF, Webster RG, Roberson PK, Mahoney J, Thompson J, Doolittle M, Lott L, Johnson P, Christoph RC.
    J Infect Dis; 1985 Dec 31; 152(6):1212-8. PubMed ID: 3905983
    [Abstract] [Full Text] [Related]

  • 12. The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children.
    Steinhoff MC, Halsey NA, Fries LF, Wilson MH, King J, Burns BA, Samorodin RK, Perkis V, Murphy BR, Clements ML.
    J Infect Dis; 1991 May 31; 163(5):1023-8. PubMed ID: 2019751
    [Abstract] [Full Text] [Related]

  • 13. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
    Gorse GJ, Belshe RB, Munn NJ.
    J Clin Microbiol; 1986 Sep 31; 24(3):336-42. PubMed ID: 3531226
    [Abstract] [Full Text] [Related]

  • 14. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.
    Alexandrova GI, Budilovsky GN, Koval TA, Polezhaev FI, Garmashova LM, Ghendon YuZ, Romanova YR, Smorodintsev AA.
    Vaccine; 1986 Jun 31; 4(2):114-8. PubMed ID: 3524050
    [Abstract] [Full Text] [Related]

  • 15. Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.
    Keitel WA, Couch RB, Cate TR, Six HR, Baxter BD.
    J Infect Dis; 1990 Jan 31; 161(1):22-6. PubMed ID: 2153185
    [Abstract] [Full Text] [Related]

  • 16. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M.
    J Infect Dis; 2000 Mar 31; 181(3):1133-7. PubMed ID: 10720541
    [Abstract] [Full Text] [Related]

  • 17. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers.
    Yamane N, Nakamura Y, Yuki M, Odagiri T, Ishida N.
    J Hyg (Lond); 1984 Apr 31; 92(2):231-42. PubMed ID: 6707472
    [Abstract] [Full Text] [Related]

  • 18. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM, Yi T, Ambrose CS.
    Vaccine; 2011 Jun 10; 29(26):4322-7. PubMed ID: 21513761
    [Abstract] [Full Text] [Related]

  • 19. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM, Snyder P, Thompson JM, Johnson PR, Wright PF.
    Vaccine; 1986 Mar 10; 4(1):50-4. PubMed ID: 3962451
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants.
    Anderson EL, Belshe RB, Burk B, Bartram J, Maassab HF.
    J Clin Microbiol; 1989 May 10; 27(5):909-14. PubMed ID: 2745699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.